Company achieves full year 2025 net sales of
Record-breaking year
Annual gross margin expansion of 140 basis points and net income growth of 54% reflect the Company's disciplined operational execution
"2025 was a truly remarkable year for Lifeway, marked by exceptional growth and operational excellence," said
Fourth Quarter 2025 Highlights
Net Sales :$55.4 million , up 18.0% year-over-year.- Gross Profit Margin: 27.8%, up 250 basis points from 25.3% last year.
- Selling, general and administrative expenses were
$11.5 million , up slightly from last year, reflecting continued investment in marketing and brand awareness. - Net Income:
$2.5 million , or$0.17 per basic and$0.16 per diluted common share, compared to a net loss of$0.2 million , or net loss of$0.01 per basic and diluted common share in the prior year.
Full Year 2025 Highlights
Net Sales :$212.5 million , highest in Company history, up 13.7% year-over-year and approximately 19% on a comparable basis, adjusted for a customer relationship the Company strategically exited in the third quarter of 2024, and a distributor shifting from Lifeway delivered to customer pick-up in late 2024, resulting in lower net sales and lower freight expense.- Gross Profit Margin: 27.4%, up 140 basis points from 26.0% last year.
- Selling, general and administrative expenses as a percentage of net sales were 19.6%, up slightly from last year, reflecting continued investment in marketing and brand awareness.
- Net Income:
$13.9 million , or$0.91 per basic and$0.89 per diluted common share, compared to$9.0 million , or$0.61 per basic and$0.60 per diluted common share in the prior year.
Expanding Kefir Visibility
Lifeway recently announced social campaigns and partnerships with highly recognized names to spotlight Lifeway Kefir in front of a nationwide audience.
- The Company launched a social-first campaign with
Chicago football starsColston Loveland andD'Andre Swift designed to highlight the market-leading, protein-forward and probiotic-packed Lifeway drinkable kefir. - The Company partnered with
Barry's to launch the Lifeway Power Play shake atBarry's Fuel Bar locations nationwide, which features Organic Plain Whole Milk Kefir and delivers a protein- and probiotic-packed boost to energize workouts and support recovery.
On-Trend Innovation
Lifeway continues to innovate and meet evolving consumer taste, expanding its product portfolio in adjacent product categories to its flagship kefir and Farmer Cheese. The Company recently announced Lifeway Kefir Butter, a probiotic, cultured butter pairing flavor with functional nutrition and available in Unsalted, Sea Salt and
Outlook
The Company reiterated its long-term target of $45–$50 million in Adjusted EBITDA1 for FY 2027 and is well positioned to deliver the strongest annual sales in Company history in FY 2026.
"Our momentum continues to build as we drive sustainable, profitable growth across the business," Smolyansky concluded. "We have laid a foundation for durable, long-term value creation, and the investments we are making today in capacity, marketing and innovation position us exceptionally well to capitalize on the tremendous opportunities ahead."
- Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is defined as Operating Income, as reported, plus Depreciation and Amortization, plus Stock-Based Compensation.
Conference Call and Webcast
A webcast with Lifeway's President and Chief Executive Officer discussing these results with additional comments and details is available through the "Investor Relations" section of the Company's website at https://lifewaykefir.com/webinars-reports/.
About
Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, unaudited estimated net sales. These statements use words, and variations of words, such as "anticipate," "plan," "project," "estimate," "potential," "forecast," "will," "continue," "future," "increase," "believe," "outlook," "expect," and "predict." You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the date of this press release, are based on current expectations of future events and thus are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond Lifeway's control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway's expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and the Lifeway's Quarterly Reports on Form 10-Q for the fiscal quarters ended
Non-GAAP Financial Measures
This press release refers to Adjusted EBITDA, which is a financial measure that has not been prepared in accordance with
We are unable to reconcile our target fiscal year 2027 Adjusted EBITDA to projected net income, the most directly comparable projected GAAP financial measure, because certain information necessary to calculate such measures on a GAAP basis is unavailable or dependent on the timing of future events outside of our control. Due to this uncertainty, the Company cannot reconcile target fiscal year 2027 Adjusted EBITDA to the nearest GAAP financial measure without unreasonable effort.
Vice President of Communications, Lifeway Foods
Email: derekm@lifeway.net
Email: dtarman@perceptualadvisors.com
General inquiries:
Phone: 847-967-1010
Email: info@lifeway.net
Unaudited Consolidated Balance Sheets (In thousands) | |||||||
2025 | 2024 | ||||||
Current assets | |||||||
Cash and cash equivalents | $ | 5,571 | $ | 16,728 | |||
Accounts receivable, net of allowance for credit losses and discounts & allowances of | 16,643 | 15,424 | |||||
Inventories, net | 11,890 | 8,678 | |||||
Prepaid expenses and other current assets | 2,627 | 2,144 | |||||
Refundable income taxes | 325 | 631 | |||||
Total current assets | 37,056 | 43,605 | |||||
Property, plant and equipment, net | 48,282 | 26,862 | |||||
Operating lease right-of use asset | 465 | 118 | |||||
11,704 | 11,704 | ||||||
Intangible assets, net | 5,818 | 6,358 | |||||
Other assets | 2,285 | 1,900 | |||||
Total assets | $ | 105,610 | $ | 90,547 | |||
Current liabilities | |||||||
Accounts payable | $ | 11,008 | $ | 10,401 | |||
Accrued expenses | 5,413 | 5,103 | |||||
Accrued income taxes | 218 | – | |||||
Total current liabilities | 16,639 | 15,504 | |||||
Operating lease liabilities | 360 | 70 | |||||
Deferred income taxes, net | 2,792 | 3,062 | |||||
Total liabilities | 19,791 | 18,636 | |||||
Commitments and contingencies (Note 9) | – | – | |||||
Stockholders' equity | |||||||
Preferred stock, no par value; 2,500 shares authorized; none issued | – | – | |||||
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,232 | 6,509 | 6,509 | |||||
(13,214) | (14,052) | ||||||
Paid-in capital | 3,843 | 4,632 | |||||
Retained earnings | 88,681 | 74,822 | |||||
Total stockholders' equity | 85,819 | 71,911 | |||||
Total liabilities and stockholders' equity | $ | 105,610 | $ | 90,547 | |||
Unaudited Consolidated Statements of Operations For the three months and twelve months ended (In thousands, except per share data) | |||||||||||||||
Three Months Ended | Twelve months Ended | ||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||
Net sales | $ | 55,361 | $ | 46,934 | $ | 212,496 | $ | 186,820 | |||||||
Cost of goods sold | 39,106 | 34,273 | 150,850 | 135,400 | |||||||||||
Depreciation expense | 892 | 764 | 3,440 | 2,846 | |||||||||||
Total cost of goods sold | 39,998 | 35,037 | 154,290 | 138,246 | |||||||||||
Gross profit | 15,363 | 11,897 | 58,206 | 48,574 | |||||||||||
Selling expenses | 5,428 | 3,487 | 19,891 | 14,743 | |||||||||||
General and administrative | 6,037 | 7,562 | 21,603 | 19,439 | |||||||||||
Amortization expense | 135 | 135 | 540 | 540 | |||||||||||
Total operating expenses | 11,600 | 11,184 | 42,034 | 34,722 | |||||||||||
Income from operations | 3,763 | 713 | 16,172 | 13,852 | |||||||||||
Other income (expense): | |||||||||||||||
Interest expense | (21) | (3) | (77) | (105 | |||||||||||
Fair value loss on investment | (75) | – | (95) | – | |||||||||||
Gain on sale of investment | – | – | 3,407 | – | |||||||||||
Gain (loss) on sale of property and equipment | – | (11) | – | (8 | |||||||||||
Other income | 50 | 77 | 279 | 230 | |||||||||||
Total other income (expense) | (46) | 63 | 3,514 | 117 | |||||||||||
Income before provision for income taxes | 3,717 | 776 | 19,686 | 13,969 | |||||||||||
Provision for income taxes | 1,176 | 936 | 5,827 | 4,944 | |||||||||||
Net income (loss) | $ | 2,541 | $ | (160) | $ | 13,859 | $ | 9,025 | |||||||
Net earnings (loss) per common share: | |||||||||||||||
Basic | $ | 0.17 | $ | (0.01) | $ | 0.91 | $ | 0.61 | |||||||
Diluted | $ | 0.16 | $ | (0.01) | $ | 0.89 | $ | 0.60 | |||||||
Weighted average common shares outstanding: | |||||||||||||||
Basic | 15,230 | 14,857 | 15,200 | 14,769 | |||||||||||
Diluted | 15,577 | 15,060 | 15,539 | 14,956 | |||||||||||
Unaudited Consolidated Statements of Cash Flows For the Years Ended (In thousands) | |||||||
2025 | 2024 | ||||||
Cash flows from operating activities: | |||||||
Net income | $ | 13,859 | $ | 9,025 | |||
Adjustments to reconcile net income to operating cash flow: | |||||||
Depreciation and amortization | 3,980 | 3,386 | |||||
Stock-based compensation | 1,947 | 2,446 | |||||
Non-cash interest expense | 19 | 17 | |||||
(Gain) loss on sale of equipment | (115) | 8 | |||||
Gain on sale of investments | (3,407) | – | |||||
Fair value loss on investment | 96 | – | |||||
Deferred income taxes | (270) | 61 | |||||
(Increase) decrease in operating assets: | |||||||
Accounts receivable | (1,219) | (1,550 | |||||
Inventories | (3,212) | 426 | |||||
Prepaid expenses and other current assets | 151 | (125 | |||||
Refundable income taxes | 306 | (631 | |||||
Increase (decrease) in operating liabilities: | |||||||
Accounts payable | 238 | 156 | |||||
Accrued expenses | (1,643) | 217 | |||||
Accrued income taxes | 218 | (474 | |||||
Net cash provided by operating activities | 10,948 | 12,962 | |||||
Cash flows from investing activities: | |||||||
Purchases of property and equipment | (27,361) | (6,697 | |||||
Proceeds from sale of equipment | 115 | 15 | |||||
Proceeds from sale of investments | 5,206 | – | |||||
Net cash used in investing activities | (22,040) | (6,682 | |||||
Cash flows from financing activities: | |||||||
Repayment of note payable | – | (2,750 | |||||
Payment of deferred financing costs | (65) | – | |||||
Net cash used in financing activities | (65) | (2,750 | |||||
Net (decrease) increase in cash and cash equivalents | (11,157) | 3,530 | |||||
Cash and cash equivalents at the beginning of the period | 16,728 | 13,198 | |||||
Cash and cash equivalents at the end of the period | $ | 5,571 | $ | 16,728 | |||
Supplemental cash flow information: | |||||||
Cash paid for income taxes, net of (refunds) | $ | 5,588 | $ | 5,987 | |||
Cash paid for interest | $ | 58 | $ | 98 | |||
Non-cash investing activities | |||||||
Accrued purchase of property and equipment | $ | 774 | $ | 407 | |||
Right-of-use assets obtained in exchange for lease obligations | $ | 426 | $ | – | |||
View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-announces-strong-fourth-quarter-and-record-breaking-full-year-2025-results-led-by-the-companys-flagship-kefir-302715358.html
SOURCE